SJM Tailor™ TARP-29 (UDI 05414734007696)Recalls & reported problems
St. Jude Medical, Inc. · ANNULOPLASTY RING · Class 2 · Implant
All models of SJM Tailor (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05414734007696), received between Apr 12, 2021 and Aug 7, 2024 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Lack of Effect” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Lack of Effect1
- Off-Label Use1
Patient problems
- Cardiovascular Dysfunction/Insufficiency1
- Ischemia1
- No Clinical Signs, Symptoms or Conditions1
- Renal Failure1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 7, 2024Lack of Effect; Lack of Effect
IT WAS REPORTED THAT ON (B)(6) 2024, A 29MM TAILOR ANNULOPLASTY RING WAS SELECTED FOR IMPLANT TO REPAIR A MITRAL VALVE. NO ASSOCIATED PATIENT SYMPTOMS WERE REPORTED. AFTER IMPLANT, MILD-MODERATE MITRAL REGURGITATION WAS STILL PRESENT VIA FOLLOW UP IMAGING, THEREFORE THE RING WAS EXPLANTED AND THE VALVE WAS REPLACED WITH A NON-ABBOTT DEVICE. THE PATIENT WAS NOT CLOSED PRIOR TO EXPLANTING THE RING. THE PATIENT STATUS WAS REPORTED AS STABLE. NO PATIENT CONSEQUENCES WERE REPORTED. THERE ARE NO ALLEGATIONS OF MALFUNCTION WITH THE RING AND THERE ARE NO ALLEGATIONS TO THE SIZING OF THE RING. THE PATIENT REMAINED HEMODYNAMICALLY STABLE THROUGHOUT THE PROCEDURE AND NO CLINICALLY SIGNIFICANT DELAY WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19929131 ↗InjuryApr 12, 2021Off-Label Use; Off-Label Use
ON (B)(6) 2017, A 29MM TAILOR FLEXIBLE ANNULOPLASTY RING WAS IMPLANTED IN THE AORTIC VALVE POSITION DURING A BICUSPID AORTIC VALVE REPAIR AND ASCENDING AORTA REPLACEMENT PROCEDURE IN A (B)(6) YEAR-OLD WOMAN. DURING THE PROCEDURE, THE DEVICE WAS PLACED BENEATH THE CORONARY OSTIA. THE PATIENT'S LEFT ANTERIOR DESCENDING CORONARY ARTERY WAS INJURED, WITH THE RESULT OF A MASSIVE LEFT VENTRICULAR ISCHEMIC INJURY(POST-OPERATIVE EJECTION FRACTION OF 10-15%), THE NEED FOR PROLONGED VASOPRESSOR, VENTRICULAR ASSIST DEVICE AND CARDIORESPIRATORY SUPPORT(TRACHEOSTOMY), A LITANY OF RELATED MULTISYSTEM INJURIES INCLUDING FOREFOOT AMPUTATIONS AND RENAL FAILURE, AND THE IMPLANTATION OF A LEFT VENTRICULAR ASSIST DEVICE(LVAD) AS A BRIDGE TO AN EVENTUAL HEART TRANSPLANTATION PERFORMED ON (B)(6) 2017 AT THE HOSPITAL (B)(6).
Patient problems: Cardiovascular Dysfunction/Insufficiency; Ischemia; Renal Failure
MAUDE report 11654031 ↗
Other RING, ANNULOPLASTY devices
- CG FUTURE™ 638BL32Medtronic, Inc. · RING, ANNULOPLASTY1 death71 reports
- PROFILE 3D® 680R28Medtronic, Inc. · RING, ANNULOPLASTY1 death67 reports
- CG FUTURE™ 638BL30Medtronic, Inc. · RING, ANNULOPLASTY1 death65 reports
- CG FUTURE™ 638RL32Medtronic, Inc. · RING, ANNULOPLASTY59 reports
- Tri-Ad™ 900SFC228Medtronic, Inc. · RING, ANNULOPLASTY4 deaths56 reports
- CG FUTURE™ 638BL34Medtronic, Inc. · RING, ANNULOPLASTY51 reports
- Contour 3D® 690R30Medtronic, Inc. · RING, ANNULOPLASTY1 death50 reports
- CG FUTURE™ 638BL28Medtronic, Inc. · RING, ANNULOPLASTY1 death47 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page